Ali Lakhani MD in Tinley Park, Illinois

Home Illinois Tinley Park

Ali Lakhani MD has Hematology/oncology as his primary medical specialty. Their primary office is: 17495 La Grange Rd in Tinley Park, Illinois.

They're a part of the: Dupage Medical Group Ltd medical group which has around 1,213 members. You can call their office at 708-226-7000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1982 (around 42 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Ali R Lakhani MD Office Phone and Directions

Ali Lakhani MD
Dupage Medical Group Ltd
17495 La Grange Rd
Tinley Park, Illinois 60487
708-226-7000

Patient Ratings
Please rate your experience with Ali Lakhani MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 708-226-7000

Enter a starting address:

Healthcare Info for Ali Lakhani MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1982
The Primary Medical Specialty for Ali Lakhani MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 42
PAC (PECOS ID)#: 0648262451
NPI #: 1568458107
NPI Created On: 09/20/2005
NPI Last Updated Listed as: 03/15/2021
Primary Taxonomy Code: 207RH0003X
License Number:
036089040
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Blood test, clotting time
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Chronic care management services at least 20 minutes per calendar month
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
Injection, denosumab, 1 mg
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788392057

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788392059

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788392061

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781012123

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781012125

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781012127

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781012129

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795205501

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795205507

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $85

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795205513

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Hematology/oncology Professionals in Tinley Park

1.
Jacob Bitran MD

18210 S Lagrange Rd
Tinley-park, IL
Advocate Health And Hospitals Corporation

2.
Arvind Kumar MD

17495 La Grange Rd
Tinley-park, IL
Dupage Medical Group Ltd

3.
Ellen Gustafson MD

17495 La Grange Rd
Tinley-park, IL
Dupage Medical Group Ltd

4.
Rupa Chennamaneni MD

18210 S Lagrange Rd
Tinley-park, IL
Advocate Health And Hospitals Corporation

5.
Daniel Frank

17495 La Grange Rd
Tinley-park, IL
Dupage Medical Group Ltd

6.
Nafisa Burhani MD

17495 La Grange Rd
Tinley-park, IL
Dupage Medical Group Ltd

Providers in Dupage Medical Group Ltd

1.Worood Abboud Md

17495 La Grange Rd
Tinley Park Il 60487-7581
Dupage Medical Group Ltd
Hematology/oncology

2.Ahmad Abdul Karim Md

301 Madison St
Joliet Il 60435-6654
Dupage Medical Group Ltd
Cardiac Electrophysiology

3.James Abraham

100 Spalding Dr
Naperville Il 60540-6552
Dupage Medical Group Ltd
Gastroenterology

4.Donald Adeli Md

133 E Brush Hill Rd
Elmhurst Il 60126-5660
Dupage Medical Group Ltd
Obstetrics/gynecology

5.Nozaina Aftab Md

30 Stratford Dr
Bloomingdale Il 60108-2201
Dupage Medical Group Ltd
Infectious Disease

6.Nozaina Aftab Md

430 Pennsylvania Ave
Glen Ellyn Il 60137-4464
Dupage Medical Group Ltd
Infectious Disease

View all 1,213 members of Dupage Medical Group Ltd medical group